List of Studies ( Metabolite:GM3 18:1;O2/24:1)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST003575 | AN005870 | Lipidomic Profiling of a Preclinical Model of Streptozotocin induced Diabetic Cardiomyopathy | Blood | Mouse | Cardiovascular disease | Baker Heart and Diabetes Institute | LC-MS |
| ST003472 | AN005707 | An Optimized Plasmalogen Dietary Supplement Remodels the Cardiac Lipidome and Proteome, Providing Greater Protection in a Male Mouse Model of Dilated Cardiomyopathy Over Females | Blood | Mouse | Heart disease | Baker Heart and Diabetes Institute | LC-MS |
| ST003472 | AN005707 | An Optimized Plasmalogen Dietary Supplement Remodels the Cardiac Lipidome and Proteome, Providing Greater Protection in a Male Mouse Model of Dilated Cardiomyopathy Over Females | Heart | Mouse | Heart disease | Baker Heart and Diabetes Institute | LC-MS |
| ST002939 | AN004824 | Role of PI3K in Atrial Myopathy: Insights from Transgenic Mouse Models and Identification of a Dysregulated PI3K Lipid Profile in Individuals with Atrial Fibrillation - Part 2 of 2, Mus musculus | Atria | Mouse | Atrial fibrillation | Baker Heart and Diabetes Institute | LC-MS |
| ST002939 | AN004824 | Role of PI3K in Atrial Myopathy: Insights from Transgenic Mouse Models and Identification of a Dysregulated PI3K Lipid Profile in Individuals with Atrial Fibrillation - Part 2 of 2, Mus musculus | Ventricles | Mouse | Atrial fibrillation | Baker Heart and Diabetes Institute | LC-MS |
| ST002938 | AN004823 | Role of PI3K in Atrial Myopathy: Insights from Transgenic Mouse Models and Identification of a Dysregulated PI3K Lipid Profile in Individuals with Atrial Fibrillation - part 1 of 2, human plasma | Blood | Human | Atrial fibrillation | Baker Heart and Diabetes Institute | LC-MS |
| ST002403 | AN003917 | Deep multi-omic profiling reveals extensive mitochondrial remodeling driven by glycemia in early diabetic kidney disease (Mitochondria) | Mitochondria | Rat | Kidney disease | Baker Heart and Diabetes Institute | LC-MS |
| ST002229 | AN003638 | Estrogen receptor α deficiency in cardiac myocytes reprograms heart-derived extracellular vesicle proteome and induces obesity in female mice (Part 1) | Blood | Mouse | Obesity | Baker Heart and Diabetes Institute | LC-MS |
| ST002229 | AN003638 | Estrogen receptor α deficiency in cardiac myocytes reprograms heart-derived extracellular vesicle proteome and induces obesity in female mice (Part 1) | Epididymal fat | Mouse | Obesity | Baker Heart and Diabetes Institute | LC-MS |
| ST002229 | AN003638 | Estrogen receptor α deficiency in cardiac myocytes reprograms heart-derived extracellular vesicle proteome and induces obesity in female mice (Part 1) | Liver | Mouse | Obesity | Baker Heart and Diabetes Institute | LC-MS |
| ST002229 | AN003638 | Estrogen receptor α deficiency in cardiac myocytes reprograms heart-derived extracellular vesicle proteome and induces obesity in female mice (Part 1) | Muscle | Mouse | Obesity | Baker Heart and Diabetes Institute | LC-MS |
| ST002229 | AN003638 | Estrogen receptor α deficiency in cardiac myocytes reprograms heart-derived extracellular vesicle proteome and induces obesity in female mice (Part 1) | Ventricles | Mouse | Obesity | Baker Heart and Diabetes Institute | LC-MS |
| ST001819 | AN002951 | EC and PVC from 14-15 month-old APOE3/3, APOE3/4 and APOE4/4 mice | Brain | Mouse | Alzheimers disease | Columbia University | LC-MS |
| ST001789 | AN002902 | Acute metabolomic changes of plasma in response to endurance exercise | Blood | Human | University of California, San Diego | LC-MS | |
| ST001140 | AN001871 | Changes in the Canine Plasma Lipidome after Short- and Long-Term Excess Glucocorticoid Exposure | Blood | Dog | National University of Singapore;University of Zurich | LC-MS | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001019 | AN001667 | Lipidomic profiling of heart and plasma of mice following swim training versus pressure overload | Blood | Mouse | Baker Heart and Diabetes Institute | LC-MS | |
| ST001019 | AN001667 | Lipidomic profiling of heart and plasma of mice following swim training versus pressure overload | Heart | Mouse | Baker Heart and Diabetes Institute | LC-MS |
